However, it is the first study revealing the different effects of PPARγ and RBP4 polymorphisms on the metabolic syndrome after multivariate analysis adjusting for anti-retroviral drug, diet and drinking in HIV-infected patients receiving anti-retroviral therapy. Here, RBP4 is linked to metabolic syndrome.